Novel mutations at a CpG dinncleotide in the ryanodine receptor in malignant hyperthemtia

Human Mutation

Volumn 11, Issue 1, 1998, Pages 45-50

  Manning, Bernadette M ^a   Quane, Kathleen A ^a   Lynch, Patrick J ^a   Urwyler, Albert ^b   Tegazzin, Vincenzo ^c   Krivosic Horber, Renee ^d   Censier, Kathrin ^b   Comi, Giacomo ^e   Adnet, Pascal ^d   Wolz, Werner ^f   Lunardi, Joel ^g   Muller, Clemens R ^f   McCarthy, Tommie V ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Traumatologic orthopaedic Hospital   (Italy)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYSTEINE; HISTIDINE; RYANODINE RECEPTOR; DINUCLEOTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; CPG ISLAND; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MALIGNANT HYPERTHERMIA; METABOLISM; MUTATION; PEDIGREE; PHENOTYPE; COMPARATIVE STUDY; GENE MUTATION; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ARGININE; CPG ISLANDS; CYSTEINE; FEMALE; GENOTYPE; HISTIDINE; HUMANS; MALE; MALIGNANT HYPERTHERMIA; MUTATION; PEDIGREE; PHENOTYPE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 0031605644     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-1004(1998)11:1<45::aid-humu7>3.3.co;2-h     Document Type: Article

References (10)

1. 2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum in COS-1 cells. Biochemistry 32:3743-3753.
2. Ellis FR, Heffron JJA (1985) Clinical and biochemical aspects of malignant hyperthermia. In Atkinson RS, Adams AP (eds): Recent Advances in Anaesthesia and Analgesia. Vol. 15. New York: Churchill Livingstone, pp 173-207.
3. European Malignant Hyperthermia Group (1984) A protocol for investigation of malignant hyperpyrexia susceptibility. Br J Anaesth 56:1267-1271.
4. Eng CD, Epstein BS, Engel WK, McKay DW, McKay R (1978) Malignant hyperthermia and central core disease in a child with congenital dislocating hips: Case presentation and review. Arch Neurol 35:189-197.
5. Fujii J, Otsu K, Zorzato F, Leon S, Khanna K, Weiler JE, O'Brien PJ, MacLennan DH (1991) Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253:448-451.
6. Gillard EF, Ostu K, Fujii J, Khanna VK, De Leon S, Derdemez J, Britt BA, Duff CL, Worten RG, MacLennan DH (1991) A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11:751-755.
7. Gillard EF, Ostu K, Fujii J, Duff C, De Leon S, Khanna VK, Britt BA, Worton RG, MacLennan DH (1992) Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics 13:1247-1254.
8. Hakamata Y, Nakai J, Takeshima H, Imoto K (1992) Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett 312:229-235.
9. Keating, KE, Quane KA, Manning BM, Heffron JJA, Lehane M, Hartung E, Urwyler A, Klausnitzer M, Muller CR, Heffron JJA, McCarthy TV (1994) Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees. Hum Mol Genet 3:1855-1858.
10. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3:1487-1495.